Okay, let's tackle this question. The user wants an explanation for an MCQ about NSAIDs with good synovial fluid concentration. First, I need to recall which NSAIDs have high tissue penetration and accumulate in synovial fluid. The core concept here is pharmacokinetics of NSAIDs, specifically their ability to reach synovial fluid, which is important for treating joint inflammation.

The correct answer is probably something like diclofenac or naproxen. Diclofenac is known for good synovial penetration. Let me verify. Diclofenac has high protein binding and lipophilicity, allowing it to cross membranes and accumulate in inflamed tissues like synovial fluid.

Now, the wrong options. Let's say the options include ibuprofen, celecoxib, and aspirin. Ibuprofen has lower protein binding and may not penetrate as well. Celecoxib is a COX-2 inhibitor, which might have different distribution. Aspirin is more water-soluble and doesn't accumulate in synovial fluid.

Clinical pearls: Remember that diclofenac's high protein binding and lipophilicity help it concentrate in inflamed joints. Also, COX-2 inhibitors like celecoxib might not have the same effect due to different pharmacokinetics.

Need to structure the explanation with all the required sections, making sure each part is concise and fits within the character limit. Check for any possible mistakes in the reasoning. For example, confirming that naproxen is also a good candidate but maybe diclofenac is more commonly cited in this context. Also, ensure that the wrong options are clearly explained as to why they don't work. Avoid using technical jargon where possible but maintain precision. Make sure the clinical pearl is a high-yield fact that's exam-relevant. Finally, end with the correct answer line as specified.

**Core Concept**
Nonsteroidal anti-inflammatory drugs (NSAIDs) with high lipophilicity and plasma protein binding efficiently penetrate synovial fluid. Diclofenac is a prototypical NSAID with this property, making it effective for intra-articular inflammation.

**Why the Correct Answer is Right**
Diclofenac has a high plasma protein binding rate (99%) and lipophilicity, allowing it to diffuse into synovial fluid via concentration gradients. Its prolonged half-life and accumulation in inflamed tissues enhance anti-inflammatory effects at the site of joint pathology. This pharmacokinetic profile supports its use in rheumatoid arthritis and osteoarthritis.

**Why Each Wrong Option is Incorrect**
**Option A:** Ibuprofen has lower lipophilicity and protein binding, limiting its synovial concentration.
**Option B:** Celecoxib (COX-2 inhibitor) is less lipophilic and does not achieve high synovial fluid levels.
**Option C:** Aspirin is water-soluble and rapidly cleared from synovial fluid, reducing efficacy for chronic joint inflammation.

**Clinical Pearl / High-Yield Fact**
Remember "DIC" (Diclofenac) for synovial penetration: high protein binding and lipophilicity drive its accumulation in inflamed joints. Avoid COX-2 inhibitors for synovial targeting due to reduced tissue penetration.

**Correct Answer: D. Diclofenac**

✓ Correct Answer: B. Diclofenac sodium